17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Fig. 5.02 A marked decrease in the mortality of<br />

uterine cancer (cervix and corpus) has been<br />

achieved in many countries. Upper curves: age<br />

group 35-64 years. Lower curves: all age groups<br />

combined. From F. Levi et al. {1637}.<br />

Fig. 5.03 Deregulation of the restriction point (R) by HPV16 E7. In quiescent cells, pRb is present in a<br />

hypophosphorylated form and is associated with transcription factors, e.g. members of the E2F family,<br />

inhibiting their transcriptional activity. When quiescent cells are exposed to mitogenic signals, G1 specific<br />

cyclin D/CDK complexes are activated and phosphorylate pRb in mid-G1 phase, causing release of active<br />

E2F and progression through the restriction point (R). E7 binding to pRb mimics its phosphorylation. Thus, E7<br />

expressing cells can enter S phase in the absence of a mitogenic signal. From M. Tommasino {2938a}.<br />

and E7. The viral oncoproteins are able<br />

to form stable complexes with cellular<br />

proteins and alter, or completely neutralize,<br />

their normal functions.<br />

The best understood interactions of E6<br />

and E7 with cellular proteins are those<br />

involving the tumor suppressor proteins<br />

TP53 and pRb, respectively. Both interactions<br />

lead to a rapid degradation of the<br />

cellular proteins via the ubiquitin pathway.<br />

The major role of TP53 is to safeguard<br />

the integrity of the genome by<br />

inducing cell cycle arrest or apoptosis,<br />

while pRb plays a key role in controlling<br />

the correct G1/S transition acting at the<br />

restriction point (R) of the cell cycle.<br />

Therefore, loss of TP53 and pRb functions<br />

results in abrogation of apoptosis<br />

and in unscheduled proliferation. Both<br />

events greatly increase the probability of<br />

H P V-infected cells evolving toward s<br />

malignancy.<br />

Clinical features<br />

Signs and symptoms<br />

Early invasive cancers can be asymptomatic.<br />

As the tumour grows and<br />

becomes exophytic, vaginal bleeding<br />

and discharge are the two most common<br />

symptoms. With lateral growth into the<br />

parametrium, the ureters become<br />

obstructed. If both ureters are obstructed,<br />

the patient presents with anuria and<br />

uraemia. Pelvic sidewall involvement can<br />

cause sciatic pain and, less commonly,<br />

lymphoedema of the lower extremities.<br />

Anterior tumour growth in advanced<br />

Table 5.01<br />

Risk factors for cervical cancer: HPV infection vs. persistence and malignant transformation.<br />

Risk factor HPV HPV persistence Reference<br />

infection and transformation<br />

Multiple sex partners + n.e. {320}<br />

Partner’s multiple partners + n.e. {320}<br />

Poor hygiene + n.e. {193}<br />

Absence of male circumcision + + {423}<br />

Immunodeficiency, HIV + + {920}<br />

High parity n.e. + {1944}<br />

Oral contraceptives n.e. + {1911}<br />

Smoking n.e. + {2826}<br />

STDs other than HPV n.e. + {108,2734}<br />

Poor nutritional status n.e. + {2324}<br />

STDs = Sexually transmitted diseases (especially C. trachomatis).<br />

n.e. = No evidence for being a risk factor at this time.<br />

Epithelial tumours 263

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!